HIV-associated psoriasis: pathogenesis, clinical features, and management.
about
Modelling epidermis homoeostasis and psoriasis pathogenesis.γδ T Cells in HIV Disease: Past, Present, and FuturePsoriasis patients are enriched for genetic variants that protect against HIV-1 diseasePsoriasis and comorbid diseases: Epidemiology.A Case of Severe HIV-Associated Psoriasis Successfully Treated with Acitretin Therapy.Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progressionIL-23 in infections, inflammation, autoimmunity and cancer: possible role in HIV-1 and AIDSSympathetic ophthalmia in HIV infection. A clinicopathological case reportContribution of the IL-17 Pathway to Psoriasis and Psoriatic Arthritis.Systematic review of the efficacy and safety of biological therapy for inflammatory conditions in HIV-infected individuals.Same-sex marriage, autoimmune thyroid gland dysfunction and other autoimmune diseases in Denmark 1989-2008.Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports.Cytosolic RNA:DNA Duplexes Generated by Endogenous Reverse Transcriptase Activity as Autonomous Inducers of Skin Inflammation in Psoriasis.Psoriasis associated with idiopathic CD4+ T-cell lymphopenia: a regulatory T-cell defect?Infections and the risk of psoriatic arthritis among psoriasis patients: a systematic review.Occult HIV infection in Japanese rupioid psoriasis.The molecular signature of murine T cell homeostatic proliferation reveals both inflammatory and immune inhibition patterns.Psoriatic arthritis.Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis.
P2860
Q27346151-1D1BE914-08F9-4370-98AF-D382C737C7A7Q28084822-D5EC2624-D1E6-47E9-9F7B-B1ACC22A6811Q28483308-E90C63D3-B4D9-4807-8DD2-4143A3EFE6FFQ30235889-54EFFBF9-0A78-4B41-92C6-5D15F1C7ECD2Q33879474-2F924BC2-4A3A-49EC-B282-83BD5C3BC9BFQ34154244-0F8A140D-39EB-4DE1-98A2-06F985366A2DQ35784621-1F86B9B1-BD76-444E-B79F-F21BF15FAF31Q36223210-D81C2DA9-621D-435D-8E05-9E512F4006C9Q38553845-68B0E78F-90C9-4EE7-AC20-282162EC170BQ38812233-86117D64-8C20-49FF-BA85-54629D0233F3Q40226043-FE1F6089-ED36-470B-90D7-B6DF6479169BQ40523577-3BE8C065-F874-4E62-B142-45013F76D28BQ41828102-1AA7190D-204C-4485-AA78-3480B346E388Q45071688-E76E48C8-64FB-4478-B646-32C1645A9AAEQ47584168-F5592D43-0A99-4476-86B9-2B105A659B29Q48219824-C1B79408-D09C-41AB-99EE-B8F1E2163D30Q50975972-54B615D3-7436-49E7-8895-6CDE6BB98FDBQ51656945-CAB4F7DA-81E7-4ADE-BA08-98E0A9CA0022Q52900365-2CB62D5C-BF70-4B6A-9029-66A571F0D0F2
P2860
HIV-associated psoriasis: pathogenesis, clinical features, and management.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HIV-associated psoriasis: pathogenesis, clinical features, and management.
@en
HIV-associated psoriasis: pathogenesis, clinical features, and management.
@nl
type
label
HIV-associated psoriasis: pathogenesis, clinical features, and management.
@en
HIV-associated psoriasis: pathogenesis, clinical features, and management.
@nl
prefLabel
HIV-associated psoriasis: pathogenesis, clinical features, and management.
@en
HIV-associated psoriasis: pathogenesis, clinical features, and management.
@nl
P2093
P1476
HIV-associated psoriasis: pathogenesis, clinical features, and management.
@en
P2093
Christopher B Bunker
Nilesh Morar
Saffron A Willis-Owen
Toby Maurer
P304
P356
10.1016/S1473-3099(10)70101-8
P577
2010-07-01T00:00:00Z